Skip to content
›

Hebei TCM Society Committee on Atrophy & Bi Syndromes Holds Election and Forum

The Hebei Province Traditional Chinese Medicine Society Committee on Atrophy and Bi Syndromes held its re-election and the Hebei Province Atrophy and Bi Difficult Diseases Forum successfully on October 28 at Hebei Yiling Hospital. This forum is part of the academic exchange project under the Yanzhao Brand, selected by the Hebei Provincial Association for Science and Technology’s Society Capacity Enhancement Plan. The forum was hosted by the Hebei Province Traditional Chinese Medicine Society and organised by Hebei Yiling Hospital and the Hebei Province TCM Society Committee on Atrophy and Bi Syndromes. Its aim was to further promote the development of TCM in treating muscle atrophy, rheumatic immune diseases, and related fields, to strengthen industry cooperation and communication, to improve the TCM prevention and treatment level of major diseases in the discipline, and to enhance the Yanzhao Brand academic exchange. Nearly 200 experts and doctors from over 60 medical institutions across 11 regions of the province, including Beijing Japan-China Friendship Hospital, Beijing Dongzhimen Hospital, Tianjin General Hospital, the First Affiliated Hospital of Zhengzhou University of Traditional Chinese Medicine, Hebei Yiling Hospital, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang City Hospital of Traditional Chinese Medicine, Tangshan City Hospital of Traditional Chinese Medicine, Hebei Second Hospital, and Shijiazhuang People’s Hospital, attended the forum in person.

At the opening ceremony, Secretary Liu Zengxiang delivered a speech on behalf of Hebei Yiling Hospital. Secretary Liu first extended a warm welcome to all leaders and experts attending the forum. Since its establishment in 1992, Hebei Yiling Hospital has developed over more than 30 years into a modern, comprehensive Grade-A tertiary hospital, a success inseparable from the support and assistance of society leaders and colleagues. He also hoped everyone would provide valuable advice and suggestions for the hospital’s construction and development. The purpose of this Atrophy and Bi Difficult Diseases Forum is to strengthen academic exchange and cooperation within the industry, continuously promote academic progress in the specialty, improve diagnosis and treatment levels to overcome global difficult diseases, and provide services to the broad patient population. Finally, he wished the forum a complete success.

Secretary-General Wu Zhi of the Hebei Chinese Medicine Society, representing the Chinese Medicine Society, expressed sincere congratulations on the meeting. Secretary-General Wu stated that this forum is one of the 2023 Society Capacity Enhancement Plan projects of the Provincial Association for Science and Technology. Inheriting, innovating, and developing TCM is an unshirkable responsibility and obligation of the Hebei Province TCM Society. He hopes that under the leadership of the newly appointed chairperson, the Atrophy and Bi Syndromes Committee will leverage its academic strengths to become a platform and opportunity for learning, exchange, mutual support, and common progress; closely follow TCM development plans; jointly explore sustainable health development through TCM; and enhance the province’s TCM diagnosis and treatment service capabilities.

Minister Lu Song of the Hebei Provincial Association for Science and Technology pointed out that this forum is a vivid practice of studying and implementing the spirit of the 20th National Congress of the Communist Party of China and General Secretary Xi Jinping’s important speeches during his inspection of Hebei, as well as a solid advancement of the Healthy China strategy. The Provincial Association for Science and Technology will continue to strongly support and serve the innovative development of the society. He hopes the society will further strengthen its own construction, unite and lead medical and scientific workers in the field of TCM atrophy and bi syndromes to closely rally around the Party, and ensure that science, technology, and medical care safeguard the health and lives of the people. He also wished the conference a complete success.

The re-election meeting of the Hebei Province Traditional Chinese Medicine Society Committee on Atrophy and Bi Syndromes was chaired by Deputy Secretary-General Liu Guixiang of the Hebei Province TCM Society. Li Jianjun, Director of the Muscle Atrophy Department at Hebei Yiling Hospital, was re-elected as Chairperson of the Committee. Li Jianjun, upon his election, stated that the Committee provides a high-quality exchange platform for research on difficult neurological diseases. Going forward, he will better rely on this platform to leverage TCM’s role in treating difficult diseases, strengthen and improve the academic research level of TCM atrophy and bi syndromes in Hebei Province, and benefit more patients.

In addition, the conference invited renowned experts and scholars to deliver keynote reports and engage in academic exchanges. Among them, Professor Wu Yiling, Academician of the Chinese Academy of Engineering, a renowned TCM cardiovascular disease expert, founder and leader of the TCM collateral disease discipline, presented an academic report titled “Qi Collateral Theory Guiding Anti-Aging Treatment” before the exchange session. Numerous original research findings on anti-aging mechanisms and experiments demonstrated exemplary contributions to the inheritance and innovative development of TCM. Professor Yan Xiaoping from Beijing Japan-China Friendship Hospital spoke on “Inheritance and Reflections on Jiao Shude-Wang Bi Syndrome.” Professor Ma Bin from Beijing University of Chinese Medicine Dongzhimen Hospital presented “TCM Treatment Considerations for Motor Neuron Disease.” Professor Yang Chunsheng from Tianjin Medical University General Hospital discussed “Advances in Treatment of Myasthenia Gravis.” Professor Luo Yaping from Hebei Provincial Hospital of Traditional Chinese Medicine spoke on “Advances in Diagnosis and Treatment of Rheumatoid Arthritis.” Professor Liu Yaling from the Second Hospital of Hebei Medical University presented “Diagnostic Advances in Amyotrophic Lateral Sclerosis.” Professor Jin Jie from the First Affiliated Hospital of Henan University of Chinese Medicine discussed “Integrated Chinese and Western Medicine Diagnosis and Treatment of Multiple System Atrophy.” Professor Li Jianjun from Hebei Yiling Hospital shared “Preliminary Exploration of TCM Diagnosis and Treatment of Motor Neuron Disease.” Professor Guo Gang gave a lecture on “Diagnosis and Differential Diagnosis of Common Clinical Arthritis.” Professor Lu Chunling spoke on “Diagnosis and Treatment of Rare Hereditary Muscle Diseases.” Director Jiang Fubin presented “Comprehensive Perspectives on Osteoporosis.” These lectures covered treatment advances, conceptual approaches, challenges, and empirical prescriptions related to TCM atrophy syndromes and modern related diseases, earning unanimous praise from attendees.

Finally, Li Jianjun, Chairperson of the Hebei Province TCM Society Committee on Atrophy and Bi Syndromes, stated that in recent years, with changes in people’s health concepts and shifts in medical models, traditional Chinese medicine, which emphasises disease prevention and follows holistic and systematic theories, has ushered in new development. It has shown remarkable efficacy not only in many common and frequently occurring diseases but also plays an important role in the prevention and treatment of major difficult diseases, compensating for many shortcomings of Western medicine in various regions. The successful convening of this forum and academic conference will enable TCM practitioners to inherit and promote traditional Chinese medicine, advance TCM inheritance and innovation, fully leverage TCM’s diagnostic and therapeutic advantages in difficult and rare diseases, and better serve the health of the people.

Related reading